News for Aethlon Medical, Inc. (AEMD)

SAN DIEGO - July 15, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage biotechnology company developing the investigation...

PR NewswireSAN DIEGO, July 15, 2025 SAN DIEGO, July 15, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage biotechnology company d

Aethlon Medical (AEMD) receives positive safety review from the Data Safety Monitoring Board (DSMB). The Hemopurifier trial advances to the next cohort

New York-based XCF Global, Inc. (SAFX) is up over 136 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Operator: Good afternoon, and welcome to the Aethlon Medical Fourth Quarter Fiscal 2025 Earnings and Corporate Update Conference Call. [Operator Instructions] Please note this event is being recorded.

Major U.S. stock indexes are poised to begin the week on solid footing after closing at record highs on Friday. Futures indicated a positive open for markets

The U.S. stock markets are poised to close June on a high note, with all three major indexes trading near record levels. The Dow Jones Industrial Average

I'll use my best judgment to complete the article based on the information gathered.

SAN DIEGO - June 27, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to tre...

As of March 31, Aethlon Medical's (AEMD) financial status shows a cash reserve of roughly $5.5 million. This information highlights the company's current cash h

Gold mining company Blue Gold Limited (BGL) is up over 297 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2025 Earnings Conference Call June 26, 2025 4:30 PM ETCompany ParticipantsJames B.

PR NewswireSAN DIEGO, June 26, 2025 Three Patients Treated in Hemopurifier® Cancer Trial; Indian Regulatory Approval Achieved; Operating Expenses Reduced

PR NewswireSAN DIEGO, June 20, 2025 SAN DIEGO, June 20, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on

Aethlon Medical (AEMD) to announce Q4 2025 financial results on June 26, 2025. Earnings call scheduled for the same day at 4:30 p.m. ET with a Q&A sessi

SAN DIEGO - June 18, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to tre...

PR NewswireSAN DIEGO, June 18, 2025 Second Patient in first cohort enrolled and treated at the Royal North Shore Hospital/University of Sydney Aethlon Adva

Aethlon Medical (AEMD) has reached a pivotal point in its Australian trial by successfully treating a second patient with its Hemopurifier device. This trial fo

MIAMI, June 17, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 83rd Emerging Growth Co